Publication of Final Terms

Aviva PLC
10 September 2024
 

                                                        

 

 

10 September 2024

 

 

 

Publication of Final Terms pursuant to the issue of £500m 6.125 per cent. Tier 2 Notes due 12 September 2054 by Aviva plc (the "Company")

 

The following Final Terms have been filed with the Financial Conduct Authority (the "FCA") and are available for viewing:

 

Final Terms dated 10 September 2024 (the "Final Terms") relating to the issue by the Company of £500m 6.125 per cent. Tier 2 Notes due 12 September 2054 under the £7,000,000,000 Euro Note Programme (the "Programme") of the Company updated on 20 June 2024. The Programme enables the Company to issue debt instruments, including a range of subordinated securities.

 

The Final Terms should be read in conjunction with the Base Prospectus dated 20 June 2024, as supplemented by a Supplemental Prospectus dated 14 August 2024 (together the "Prospectus").

 

To view the Final Terms, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/6242D_1-2024-9-10.pdf

 

Copies of the following documents are also available from the websites listed below:

 

Prospectus approved by the FCA on 20 June 2024 relating to the Programme

http://www.rns-pdf.londonstockexchange.com/rns/4430T_1-2024-6-21.pdf

 

Supplemental Prospectus approved by the FCA on 14 August 2024 relating to the Programme

http://www.rns-pdf.londonstockexchange.com/rns/4957A_1-2024-8-14.pdf

 

The Prospectus, the Supplemental Prospectus and the documents incorporated by reference therein have been submitted to the National Storage Mechanism and are available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

-ends-

 

 

Enquiries:

 

 Media:




 Andrew Reid

+44 (0)7800 694 276

 Sarah Swailes

+44 (0)7800 694 859



 Analysts:




 Greg Neilson

+44 (0)7800 694564

 Joel von Sternberg

+44 (0)7384 231 238

 Michael O'Hara

+44 (0)7387 234 388

 

 

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

 

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any State or other jurisdiction of the United States, and are subject to Unites States tax law requirements. Subject to certain exceptions, the securities referred to herein may not be offered, sold or delivered in the United States (as defined in Regulation S under the Securities Act) or to, or for the account or benefit of, U.S. persons (as defined in the U.S. Internal Revenue Code of 1986, as amended, and regulations thereunder). The Prospectus may not be accessed from, or transmitted in or into, the United States. Accordingly, these securities may not be offered, sold or delivered in the United States.

 

Please note that the information contained in the Supplementary Prospectus and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed.  Prior to relying on the information contained in the Supplementary Prospectus or the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Aviva (AV.)
UK 100

Latest directors dealings